$STLN Income Statement | Understand Stock

$STLN

$6.59 +$0.30 (4.77%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating revenue
Patient services
Dispensary
Specialty pharmacy
Clinical trials & other
Total operating revenue
Operating expenses
Direct costs
Patient services
Dispensary
Specialty pharmacy
Clinical trials & other
Goodwill impairment charges
Selling, general and administrative expense
Depreciation and amortization
Total operating expenses
Loss from operations
Other non-operating expense (income)
Interest expense
Interest expense, net
Change in fair value of derivative warrant liabilities
Change in fair value of earnout liabilities
Change in fair value of conversion option derivative liabilities
Gain on loan forgiveness
Other, net
Total other non-operating expense

Loss before provision for income taxes
Income tax benefit
Net loss
Net loss per share attributable to common stockholders:
Net loss attributable to common stockholders, basic
Net loss attributable to common stockholders, diluted
Weighted-average number of shares outstanding, basic (in shares)
Weighted-average number of shares outstanding, diluted (in shares)
Net loss per share attributable to common stockholders, basic (in dollars per share)
Net loss per share attributable to common stockholders, diluted (in dollars per share)

Comments